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imaging and digitization performed over a 2 sec period. Mean videointen-
sity in the balloon cross-sectional area was measured for every consecutive
digitized image. Results: (1) Videointensity was found to be directly related
to temperature induced changes in microbubble volume. (2) Under continu-
ous ultrasonic irradiation, videointensity decreased over time. The slope of
this decrease, defined as destruction index, correlated with both transmit-
ted power and temperature, reflecting the destructive effects of irradiation,
which were more pronounced at higher temperatures.
Conclusion: Temperature is a major factor affecting stability and reflec-
tivity of Albunex® microspheres. To improve the reproducibility of contrast
enhancement, the temperature of the contrast media should be carefully
controlled.
Experimental Myocardial Ischemia/Infarction
farct zone myeloperoxidase was reduced from 0,28 ± 0.1 to 0,1 ± 0,1 U/l00
mg (p = 0,03),
Conclusion: Bolus IV administration of TLC-C53 at reperfusion suppresses
expression of ICAM-l and P-Selectin on ischemic but viable endothelium and
prevents secondary (presumably lethal) WBC myocardial infiltration, The ef-
fect of TLC-C53 on WBC adhesion molecule expression may be less marked,
We propose that inhibition of adhesion molecules in ischemic myocardium
is the principle mechanism of infarct salvage by TLC-C53.
A Monoclonal Antibody Directed Against ICAM·1
Reduces Myocardial Stunning Following
Ischemia and Reperfusion
David J, Lefer, David M, Flynn, Scott Morehouse, Khoa D, Vo, Andrew J, Buda,
Tulane University School of Medicine, New Orleans, LA
Tuesday, March 21, 1995, 3:00 p,m.-5:00 p.m.
Ernest N. Morial Convention Center, Hall E
Presentation Hour: 4:00 p.m.-5:00 p.m.
Previous studies have demonstrated that monoclonal antibodies (MAbs) that
neutralize ICAM-l reduce myocardial necrosis following ischemia and reper-
fusion, We investigated the effects of a MAb directed against rat ICAM-l
(1A29) in a rat model of myocardial reperfusion injury, Isolated, Krebs buffer
perfused rat hearts (n = 7/group) were subjected to 20 min of global is-
chemia followed by 45 min of reperfusion, Forty million human neutrophils
(PMNs) and 5 cc of rat plasma were infused into each heart during the first
5 min of reperfusion, Immunohistochemical staining of ischemic-reperfused
myocardium revealed prominent endothelial ICAM-1 expression and PMN
accumulation in coronary arterioles and venules in untreated hearts, In addi-
tion, left ventricular developed pressure ILVDP), pressure-rate product (PRP).
and coronary flow (CF) were measured at baseline and at 5 minute inter-
vals throughout the 45 min reperfusion period, When compared to control
hearts receiving human PMNs and rat plasma alone, treatment with lA29
1300 iLg/heart) significantly (p < 0.Q1) enhanced recovery of LVOP after 45
min of reperfusion (90,8 ± 12,7% vs. 42,8 ± 5,5%), The recovery of PRP
at 45 min of reperfusion was 89,7 ± 15,6% in lA29 treated hearts com-
pared to 42,2 ± 5,3% in the control hearts (p < 0,02), Furthermore, treat-
ment with 1A29 significantly preserved CF at 45 min of reperfusion (73,9 ±
5.3% vs, 48,9 ± 6,9%, P < 0,05). Histological analysis of hearts receiVing
lA29 demonstrated a significant reduction in PMN accumulation, We con-
clude that inhibition of ICAM-l mediated PMN adhesion in the initial phase
of reperfusion significantly attenuates neutrophil induced postischemic my-
ocardial contractile dysfunction,
Diagnostic Abillty of a Single Admission Value of
Serum Myoglobin, Troponin-T and CK·MB In
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Admission serum myoglobin 1Mb) and troponin-T(TNT) levels were evaluated
vs admission CK-MB (mass assay) levels and the admission ECG ST elevation
(STtl >2 m V. for their diagnostic values in patients with suspected acute
myocardial infarction (AMI) before thrombolytic treatment.
Consecutive patients In = 153), presenting with chest pain at rest >30
min but <12 hrs, unresponsive to nitroglycerin, were included, The ultimate
diagnosis of AMI was based on a rise and fall pattern of CK-MB (catalytic
assay) and a peak value> 15 U/I, and/or the development of Q-waves on the
ECG.
Cytoklne Antagonists Increase In the Circulation
During Myocardial Ischemia and Reperfuslon
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In the present research, we tested the idea that cytokine antagonists are
released during acute myocardial ischemia and reperfusion to counteract
pro-inflammatory effects of cytokines. We investigated changes in plasma
concentrations of the anti-cytokine molecules a-melanocyte stimulating hor-
mone (a-MSH), interleukin-1 receptor antagonist (IL-1 raj, and soluble tumor
necrosis factor receptor (s TNF r) in patients with acute myocardial infarction
(AMI) or unstable angina (UA) treated with thrombolytic agents compared to
patients who did not receive thrombolysis, The study includes 32 pts pre-
senting with prolonged chest pain and ST-segment changes on ECG; the
final diagnosis was AM I in 24 and UA in 8 patients; 26 pts received throm-
bolytic therapy, There was no difference in the duration of chest pain at
presentation between the thrombolysis and no thrombolysis groups, Blood
samples were collected at admission in the CU and at 3 h intervals for 24
h, Comparisons of plasma a-MSH concentrations in thrombolysis and un-
treated groups showed highly significant differences: whereas concentra-
tions of the peptide were elevated in early samples of patients treated with
a thrombolytic agent, they were consistently low in untreated subjects, IL-l
ra levels were likewise greater 3 and 6 h post treatment in patients who
underwent thrombolysis, whereas there was no significant difference for
plasma s TN Fr between the two groups. We suggest that during myocardial
ischemia and reperfusion anti-cytokine molecules released within the injured
myocardium reduce inflammation caused by cytokines and other mediators
of inflammation.
Suppression of ICAM-1 and P-Selectin Adhesion
Molecule Expression by Bolus IV Llposomal
PGE1 (TLC-C53) Immediately Prior to
Reperfuslon in a Two Hour Canine
Infaret/Reperfuslon Model
The admission Mb, TNT and CK-MB concentrations were significantly
higher in the AMI patients compared to the No-AMI patients, and there was
no overlap of the 95% CI of the medians between the two groups, For AMI
diagnosis, the predictive values of positive and negative tests were 0.84 and
0,62 for Mb > 11°iL9/l; 0,70 and 0,62 for TNT >0,02 iLg/l; 1.00 and 0,53 for
CK-MB >9,5 iLg/l, and 0.85 and 0,67 for the ECG STt,
Conclusion: A rise in serum Mb and TNT at admission, even below the
usual diagnostic cut-off values for AMI diagnosis, has an acceptable diag-
nostic accuracy, For more prompt and widespread use of fibrinolytic therapy
we propose a lowering of the diagnostic cut-off values for serum Mb, TNT
and CK-MB for admission diagnosis of MI.
Richard Smalling, Margaret Uthman, Nagendra Ramanna, Edward Yeh,
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Wayne Smith, Mark Entman, Andrew Janoff, U r Medical School and Baylor College
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Bolus administration of 2 iLlkg Liposomal PGE l (TLC-C53) after 2 hrs of is-
chemia inhibits WBC accumulation into ischemic tissue and significantly re-
duces infarct size upon reperfusion. To test the hypothesis that inhibition of
adhesion molecule expression was the mechanism of this observation we
studied 11 dogs subjected to 2 hrs of ischemia followed by 3 hrs of reper-
fusion, Animals were randomly assigned to receive either placebo or 2iL/kg
TLC-C53 just prior to reperfusion, Samples obtained from the coronary sinus
at baseline and at various intervals throughoutthe experiment were analyzed
for expression of L-Selectin (CL2) and C011 b (MY 904) on WBC using indi-
rect immunofluorescence and flow cytometry. After sacrifice, tissue samples
obtained from the infarct, border, risk and control regions were analyzed for
WBC infiltration (myeloperoxidase) and expression of ICAM-1 (CL18) and P-
Selectin (M03) on the endothelium using immuno-histochemistry, Intensity
of staining was graded from °(no stain I to 31intense stain),
Results: No differences in WBC mean channel fluorescence between the
treatment and control groups could be detected for either L-Selectin or
C011 b. Risk region expression of ICAM-l was reduced from 2,6 ± 0,6 to
0.9 ± 0.6 (p < 0,001) and P-Selectin from 1,6 ± 0,6 to 0,9 ± 0,8 (p < 0,01), In-
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